Blog: NOVO INTEGRATED SCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 7.01. Regulation FD Disclosure.

On June 23, 2022, Novo Integrated Sciences, Inc. (the “Company”) issued a press
release announcing that Rob Mattacchione, CEO and Board Chairman, has been
invited by the American Association of Physicians of Indian Origin (AAPI) to
present during AAPI’s 40th Annual Convention’s CEO Forum to discuss advancing
the Future of Healthcare: Technology, Transformation and Beyond, on Saturday
June 25, 2022 at 4:30 p.m. CDT in San Antonio, Texas. A copy of the press
release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information included in Item 7.01 to this Current Report on Form 8-K,
including Exhibit 99.1, shall not be deemed to be “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section, nor shall such
information be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing. The information set
forth under this Item 7.01 shall not be deemed an admission as to the
materiality of any information in this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.



Exhibit No.   Description

99.1            Press release issued by the registrant on June 23, 2022.
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s